Deficiency of invariant natural killer T cells in coeliac disease

被引:28
作者
Grose, R. H. [1 ]
Cummins, A. G. [1 ]
Thompson, F. M. [1 ]
机构
[1] Queen Elizabeth Hosp, Dept Gastroenterol & Hepatol, Woodville, SA 5011, Australia
关键词
D O I
10.1136/gut.2006.095307
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Immunoregulatory invariant natural killer (iNK) T cells rapidly produce interleukin (IL)-4 and other cytokines that suppress a Th1 response and are deficient in some autoimmune diseases. Aim: The aim of this study was to investigate any deficiency of iNK T cells in coeliac disease. Methods: Blood was collected from 86 subjects with coeliac disease and from 152 healthy control subjects for investigation of V alpha 24+ T cells by flow cytometry. iNK T cells were assessed by V alpha 24 and alpha-galactosylceramide/CD1d tetramer markers in 23 normal controls and 13 subjects with coeliac disease. Intracellular IL-4 was measured after anti-CD3 antibody stimulation. Duodenal biopsies were obtained in a subgroup of subjects with coeliac disease and control subjects for V alpha 24 mRNA expression using relative PCR and for V alpha 24+ T cells by immunofluorescence. Results: The mean numbers of circulating V alpha 24+ T cells and iNK T cells in coeliac disease were 27% (p < 0.001) and 16% (p < 0.001), respectively, of levels in control subjects. After in vitro anti-CD3 stimulation, numbers of IL-4+ producing iNK T cells from subjects with coeliac disease were unchanged but increased by 21% in control subjects. In subjects with coeliac disease, V alpha 24 mRNA intestinal expression was reduced to 17% (p < 0.001) by relative PCR and numbers of intestinal V alpha 24+ T cells were 16% (p < 0.01) of levels in control subjects. Conclusions: We conclude that V alpha a24+ T cells and iNK T cells are deficient in coeliac disease. We speculate that this deficiency could contribute to the failure of immunological oral tolerance that seems to underlie this disease.
引用
收藏
页码:790 / 795
页数:6
相关论文
共 38 条
[1]
In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope [J].
Anderson, RP ;
Degano, P ;
Godkin, AJ ;
Jewell, DP ;
Hill, AVS .
NATURE MEDICINE, 2000, 6 (03) :337-342
[2]
Association between alpha beta TCR(+)CD4(-)CD8(-) T-cell deficiency and IDDM in NOD/Lt mice [J].
Baxter, AG ;
Kinder, SJ ;
Hammond, KJL ;
Scollay, R ;
Godfrey, DI .
DIABETES, 1997, 46 (04) :572-582
[3]
Parallels and distinctions between T and NKT cell development in the thymus [J].
Berzins, SP ;
Uldrich, AP ;
Pellicci, DG ;
McNab, F ;
Hayakawa, Y ;
Smyth, MJ ;
Godfrey, DI .
IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (03) :269-275
[4]
GLUTEN SPECIFIC SUPPRESSOR T-CELL DYSFUNCTION IN CELIAC-DISEASE [J].
CORAZZA, GR ;
SARCHIELLI, P ;
LONDEI, M ;
FRISONI, M ;
GASBARRINI, G .
GUT, 1986, 27 (04) :392-398
[5]
Di Sabatino A, 1998, IMMUNOLOGY, V95, P572
[6]
DIETERICH W, 1997, NAT MED, V3, P776
[7]
FERGUSON A, 1975, LANCET, V1, P895
[8]
NKT cell cytokine imbalance in murine diabetes mellitus [J].
Frey, AB ;
Rao, TD .
AUTOIMMUNITY, 1999, 29 (03) :201-214
[9]
NKT cells: facts, functions and fallacies [J].
Godfrey, DI ;
Hammond, KJL ;
Poulton, LD ;
Smyth, MJ ;
Baxter, AG .
IMMUNOLOGY TODAY, 2000, 21 (11) :573-583
[10]
OCCURRENCE OF LARGE GRANULAR LYMPHOCYTES AND NATURAL-KILLER-CELLS IN THE EPITHELIUM OF THE GUT DISTINGUISHES 2 DIFFERENT CELIAC DISEASES [J].
HADZISELIMOVIC, F ;
EMMONS, LR ;
SCHAUB, U ;
SIGNER, E ;
BURGINWOLFF, A ;
KRSTIC, R .
GUT, 1992, 33 (06) :767-772